Universitätsklinikum Augsburg

Treatment choices and neuropsychological symptoms of a large cohort of early MS (2018) Von Bismarck O, Dankowski T, Ambrosius B, Hessler N, Antony G, Ziegler A, Hoshi MM, et al. Journal article Changes of disease characteristics and disease-modifying treatment within one year in the National German MS cohort (2018) Ambrosius B, Hessler N, Antony G, Konig IR, Hoshi MM, Aly L, Luessi F, et al. Conference contribution DNA methylation-based classification of central nervous system tumours (2018) Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, Koelsche C, et al. Journal article Alemtuzumab as rescue therapy in a cohort of 50 relapsing-remitting MS patients with breakthrough disease on fingolimod: a multi-center observational study (2018) Huhn K, Bayas A, Doerck S, Frank B, Gerbershagen K, Hellwig K, Kallmann B, et al. Journal article The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis (2018) Hammer A, Waschbisch A, Kuhbandner K, Bayas A, Lee DH, Duscha A, Haghikia A, et al. Journal article Influence of PCO2 Control on Clinical and Neurodevelopmental Outcomes of Extremely Low Birth Weight Infants (2018) Thome UH, Dreyhaupt J, Genzel-Boroviczeny O, Bohnhorst B, Schmid M, Fuchs H, Rohde O, et al. Journal article Invagination as Manifestation of a Perivascular Epithelioid Cell Neoplasm (PEComa) of the Colon (2018) Neuhaus L, Probst A, Messmann H, Siebert L, Vlasenko D, Agaimy A, Ting S Journal article Sellar Region Atypical Teratoid/Rhabdoid Tumors (ATRT) in Adults Display DNA Methylation Profiles of the ATRT-MYC Subgroup (2018) Johann PD, Bens S, Oyen F, Wagener R, Giannini C, Perry A, Raisanen JM, et al. Journal article European Multicenter Study for the Evaluation of a Dual-Layer Flow-Diverting Stent for Treatment of Wide-Neck Intracranial Aneurysms: The European Flow-Redirection Intraluminal Device Study (2018) Killer-Oberpfalzer M, Kocer N, Griessenauer CJ, Janssen H, Engelhorn T, Holtmannspotter M, Buhk JH, et al. Journal article Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells (2018) Mathew NR, Baumgartner F, Braun L, O'Sullivan D, Thomas S, Waterhouse M, Mueller TA, et al. Journal article